Systemic lupus erythematosus

2,463,596views

Systemic lupus erythematosus

Core Conditions

Core Conditions

Plasmodium species (Malaria)
Antimalarials
HIV and AIDS: Pathology review
Testicular cancer
Testicular and scrotal conditions: Pathology review
Testicular tumors: Pathology review
Colorectal cancer
Colorectal cancer: Clinical
Colorectal cancer: Clinical sciences
Colorectal polyps and cancer: Pathology review
Colorectal cancer screening: Clinical sciences
Heart failure
Heart failure: Pathology review
Chronic kidney disease: Clinical sciences
Acute coronary syndrome: Clinical sciences
Angina pectoris
Atrial fibrillation
Ventricular tachycardia
Heart blocks: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Eye conditions: Retinal disorders: Pathology review
Multiple sclerosis
Demyelinating disorders: Pathology review
Ascending and descending spinal tracts
Personality disorders: Pathology review
Schizophrenia spectrum disorders: Pathology review
Typical antipsychotics
Atypical antipsychotics
Psychiatric emergencies: Pathology review
Back pain: Pathology review
Anatomy clinical correlates: Bones, joints and muscles of the back
Osteoporosis
Osteoporosis: Clinical sciences
Osteoporosis medications
Bones of the vertebral column
Lordosis, kyphosis, and scoliosis
Vessels and nerves of the vertebral column
Muscles of the back
Cauda equina syndrome
Blood groups and transfusions
Blood products and transfusion: Clinical
Gestational hypertension, preeclampsia, eclampsia, and HELLP: Clinical sciences
Approach to hypertensive disorders in pregnancy: Clinical sciences
Preeclampsia & eclampsia
Aortic dissections and aneurysms: Pathology review
Aortic dissection
Aortic aneurysms and dissections: Clinical
Aortic dissection: Clinical sciences
Abdominal aortic aneurysm: Clinical sciences
Epstein-Barr virus (Infectious mononucleosis)
Leukemias: Pathology review
Acute leukemia
Complement system
Immune thrombocytopenia
Heparin-induced thrombocytopenia
Thrombotic thrombocytopenic purpura
Essential thrombocythemia (NORD)
Systemic lupus erythematosus
Systemic lupus erythematosus: Clinical sciences
Antiphospholipid syndrome
Treponema pallidum (Syphilis)
Fever of unknown origin: Clinical
Oral cancer
Anal cancer: Clinical sciences
Thyroid cancer
Gastric cancer
Hepatitis A and Hepatitis E virus
Hepatitis B and Hepatitis D virus
Viral hepatitis
Autoimmune hepatitis
Hepatitis C virus
Viral hepatitis: Pathology review
Alcohol-induced hepatitis: Clinical sciences
Hepatitis C: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis A and E: Clinical sciences
Viral hepatitis: Clinical
Approach to jaundice (conjugated hyperbilirubinemia): Clinical sciences
Cushing syndrome
Graves disease
Chronic leukemia
Non-Hodgkin lymphoma
Hodgkin lymphoma
Stroke: Clinical
Ischemic stroke
Subarachnoid hemorrhage
Intracerebral hemorrhage
Gallbladder disorders: Pathology review
Approach to biliary colic: Clinical sciences
Biliary colic
Gallstone ileus
Anaphylaxis: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Malaria: Clinical sciences
Sepsis: Clinical sciences
Approach to shock: Clinical sciences
Polymyalgia rheumatica
Rheumatoid arthritis
Measles virus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Hyponatremia
Electrolyte disturbances: Pathology review
Hyperkalemia
Hypercalcemia
Hypokalemia
Hypernatremia
Vasculitis: Pathology review
Vasculitis
Lymphomas: Pathology review
Myelodysplastic syndromes
Polycythemia vera (NORD)
Pulmonary transfusion reactions: Clinical sciences
Kawasaki disease
Upper respiratory tract infection
Febrile neutropenia: Clinical sciences
Severe chronic neutropenia (NORD)
Approach to postoperative respiratory distress: Clinical sciences
Approach to a postoperative fever: Clinical sciences
Atelectasis: Clinical sciences
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Cystic fibrosis
Cystic fibrosis: Pathology review
Dyslipidemias: Pathology review
Hyperthyroidism
Hypothyroidism: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism
Laryngitis
Nasal polyps
Diabetes insipidus and SIADH: Pathology review

Transcript

Watch video only

Content Reviewers

Alright, “systemic lupus erythematosus,” k we totally got this. “Systemic” is easy, and refers to affecting multiple organs in the body.

“Erythematosus” means reddening of the skin, alright alright.

Lupus” is latin for “wolf”. So affects multiple organs wolf...reddening of the skin?

Not exactly, the modern use of lupus usually refers to a variety of diseases that affect the skin...which was possibly originally used since these diseases resemble a wolf bite on the patients’ skin.

Is that true? Who knows. At any rate, systemic lupus erythematosus, or SLE, sometimes just lupus, is a disease that’s systemic, and affects a wide variety of organs, but notably often causes red lesions on the skin.

But how does lupus affect all these organs? Well usually the immune system protects the body’s tissues from invaders, but lupus is an autoimmune disease, which means that immune cells start attacking the very tissues their supposed to protect.

With lupus, essentially any tissue or organ can be targeted.

And just like a ton of other autoimmune diseases though, it’s not completely clear why it develops, and like most diseases it’s the result of both genetics and the environment.

Alright so let’s go over a specific scenario to show how this plays out.

Let’s say this guy has susceptibility genes—genes that make him susceptible to getting lupus, and he’s exposed to UV radiation in sunlight, which we know is an environmental risk factor for lupus.

Well, given enough UV rays, think like sunburn, the cell’s DNA can become so badly damaged, that the cell undergoes programmed cell death, or apoptosis, and it dies.

This produces all these little apoptotic bodies, and exposes the insides of the cell, including parts of the nucleus, like DNA, histones, and other proteins, to the rest of the body.

Well those susceptibility genes specifically have an effect on this person’s immune system such that their immune cells are more likely to think that these are foreign, or antigens, and since they’re from the nucleus, we call them nuclear antigens, and immune cells try to attack them.

Not only that though, susceptibility genes also cause this person to have less effective clearance, essentially they aren’t as good at getting rid of the apoptotic bodies and so they end up having more nuclear antigens floating around.

This means that B cells might swing by, see them, and start the production of antibodies against these pieces of nucleus, which are called antinuclear antibodies, and these guys are present in almost all cases of lupus.

Alright so those antinuclear antibodies bind to the nuclear antigens, forming antigen-antibody complexes.

These complexes can get into the blood and then drift away and deposit or stick to the vessel wall in all sorts of different organs and tissues like the kidneys, skin, joints, heart.

Deposited complexes then initiate a local inflammatory reaction, which causes damage through the activation of the complement system, which, after a huge cascade of enzyme activation, leaves cell membranes with channels that let fluid and molecules go in and out all willy nilly, causing the cell to burst and die, usually though you’d want this to happen to foreign cell or an infected cell, not healthy cells.

When tissues become damaged as a result of these immune complexes, it’s known as a type III hypersensitivity reaction.

UV radiation isn’t the only way to damage cells, though, right?

It therefore isn’t the only trigger that’s thought to be associated with lupus—other potential triggers that have been associated with SLE include cigarette smoking, viruses, bacteria, use of certain medications like procainamide, hydralazine, and isoniazid, as well as sex hormones, particularly estrogen, which might be partly why lupus is more common in women, especially considering it’s about 10 times more common in women than men during reproductive years, but only about 2 or 3 times more common in childhood or past the age of 65.

Okay okay, as a quick recap, the model that’s generally thought to be what leads to SLE starts with some environmental trigger, which damages cells, and causes apoptosis and the release of nuclear antigens.

At this point, the genetic components come in, and the person likely has certain genes that make them not so good at clearing these apoptotic bodies and nuclear antigens, so you end up with a lot of nuclear antigens floating around.

In combination, they probably also have genes that cause their immune cells to recognize these nuclear antigens as foreign, which initiates an immune response, creates antinuclear antibodies that bind to antigens and then float around and deposit in various tissues, which causes inflammation.

These deposits and inflammation seem to be the cause of most of the symptoms of lupus, which remember is a type III hypersensitivity reaction.

Many patients, though, also develop antibodies targeting other cells like red and white blood cells, and molecules like various phospholipids, which can mark them for phagocytosis and destruction, leading to additional symptoms.

Key Takeaways

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease in which the body's immune system mistakenly attacks healthy tissue. SLE most often harms the heart, joints, skin, lungs, blood vessels, liver, kidneys, and nervous system. Common symptoms of SLE can include fatigue, joint pain, rash, fever, and anemia. The course of the disease is unpredictable, with periods of illness (called flare-ups) alternating with remissions. Treatment typically involves medications to manage symptoms, reduce inflammation, and suppress the immune system.